Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124

NCT03087968 is registered in ClinicalTrials.gov with HepQuant, LLC as lead sponsor.

NCT NCT03087968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03087968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124
Lead sponsor
HepQuant, LLC
Phase
Phase 1
Overall status
Withdrawn
Start date
July 31, 2016
Completion date
September 13, 2017
Enrollment
0 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

severe alcoholic hepatitis